Washington, D.C.—The Federal Trade Commission has sent letters to 50 more marketers nationwide, warning them to stop making unsubstantiated claims that their products and therapies can treat or prevent COVID-19, according to a press release. FTC has sent similar letters to more than 120 companies and individuals. Letters were sent...
Washington, D.C.—The Food and Drug Administration (FDA) announced that the FDA and Federal Trade Commission (FTC) issued warning letters to three companies for selling fraudulent COVID-19 products. The letters went to Gaia’s Whole Healing Essentials LLC, Homeomart Indibuy, and Health Mastery Systems DBA Pure Plant Essentials. Gaia’s Whole Healing Essentials...
Silver Spring, MD—The U.S. Food and Drug Administration (FDA) announced that warning letters were issued to 15 companies for illegally selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). The 15 companies that received warning letters (with links to the letters):...
Washington, D.C.--The Federal Trade Commission announced that, as part of its regular monitoring of health-related advertising claims, it sent warning letters to three companies that sell oils, tinctures, capsules, gummies, and creams containing cannabidiol (CBD) from cannabis. The FTC did not identifying the three companies publicly, but said the letters...
Washington, D.C.--The Food and Drug Administration (FDA) announced that it has posted warning letters to five manufacturers of homeopathic products for significant violations of current good manufacturing practice (cGMP) regulations. “It’s our public health obligation to protect consumers from unsafe products,” FDA Acting Commissioner Ned Sharpless, M.D., said in the...
Washington, D.C.--The U.S. Food and Drug Administration (FDA) sent four warning letters about violations of current good manufacturing practice (CGMP) regulations to companies that produce homeopathic drug products, including King Bio Inc., Red Mountain Inc., Tec Laboratories Inc. and B. Jain Pharmaceuticals Pvt. Ltd., according to a news release. The...
Washington, D.C. — On October 31, the U.S. Food and Drug Administration (FDA) sent a warning letter to four companies which sell hemp oils marketed as having cannabidiol (CBD), a non-psychoactive cannabinoid found in hemp that is considered to have a variety of health benefits. Unfortunately, these benefits are not...
